Efficient generation of human IgA monoclonal antibodies

Journal of Immunological Methods

Volumn 422, Issue , 2015, Pages 102-110

  Lorin, Valérie ^a,b   Mouquet, Hugo ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

Affinity size exclusion chromatography; Antibodies; IgA; Protein purification; Transient recombinant expression system

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; VIRUS ENVELOPE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CLONING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GEL PERMEATION CHROMATOGRAPHY; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; PRIORITY JOURNAL; TRANSIENT TRANSFECTION; BIOSYNTHESIS; CELL LINE; GENE REARRANGEMENT; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CELL LINE; CLONING, MOLECULAR; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HEK293 CELLS; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN ISOTYPES; RECOMBINANT PROTEINS;

EID: 84930872929     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2015.04.010     Document Type: Article

References (41)

1. Baldi L., Hacker D.L., Meerschman C., Wurm F.M. Large-scale transfection of mammalian cells. Methods Mol. Biol. 2012, 801:13.
2. Benckert J., Schmolka N., Kreschel C., Zoller M.J., Sturm A., Wiedenmann B., Wardemann H. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J. Clin. Invest. 2011, 121:1946.
3. Beyer T., Lohse S., Berger S., Peipp M., Valerius T., Dechant M. Serum-free production and purification of chimeric IgA antibodies. J. Immunol. Methods 2009, 346:26.
4. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7297.
5. Di Niro R., Mesin L., Raki M., Zheng N.Y., Lund-Johansen F., Lundin K.E., Charpilienne A., Poncet D., Wilson P.C., Sollid L.M. Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa. J. Immunol. 2010, 185:5377.
6. Di Niro R., Mesin L., Zheng N.Y., Stamnaes J., Morrissey M., Lee J.H., Huang M., Iversen R., du Pre M.F., Qiao S.W., Lundin K.E., Wilson P.C., Sollid L.M. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat. Med. 2012, 18:441.
7. Hayes J.M., Cosgrave E.F., Struwe W.B., Wormald M., Davey G.P., Jefferis R., Rudd P.M. Glycosylation and Fc receptors. Curr. Top. Microbiol. Immunol. 2014, 382:165.
8. Herve M., Xu K., Ng Y.S., Wardemann H., Albesiano E., Messmer B.T., Chiorazzi N., Meffre E. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. J. Clin. Invest. 2005, 115:1636.
9. Isnardi I., Ng Y.S., Srdanovic I., Motaghedi R., Rudchenko S., von Bernuth H., Zhang S.Y., Puel A., Jouanguy E., Picard C., Garty B.Z., Camcioglu Y., Doffinger R., Kumararatne D., Davies G., Gallin J.I., Haraguchi S., Day N.K., Casanova J.L., Meffre E. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 2008, 29:746.
10. Kaetzel C.S. Mucosal Immune Defense: Immunoglobulin A 2007, Springer, New York.
11. Kaur K., Sullivan M., Wilson P.C. Targeting B cell responses in universal influenza vaccine design. Trends Immunol. 2011, 32:524.
12. Kiyotaki M., Cooper M.D., Bertoli L.F., Kearney J.F., Kubagawa H. Monoclonal anti-Id antibodies react with varying proportions of human B lineage cells. J. Immunol. 1987, 138:4150.
13. Langley R., Wines B., Willoughby N., Basu I., Proft T., Fraser J.D. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J. Immunol. 2005, 174:2926.
14. Liu C., Dalby B., Chen W., Kilzer J.M., Chiou H.C. Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells. Mol. Biotechnol. 2008, 39:141.
15. Mantis N.J., Rol N., Corthesy B. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 2011, 4:603.
16. Meffre E. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann. N. Y. Acad. Sci. 2011, 1246:1.
17. Menard L., Saadoun D., Isnardi I., Ng Y.S., Meyers G., Massad C., Price C., Abraham C., Motaghedi R., Buckner J.H., Gregersen P.K., Meffre E. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J. Clin. Invest. 2011, 121:3635-3644.
18. Menard L., Samuels J., Ng Y.S., Meffre E. Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis. Arthritis Rheum. 2011, 63:1237.
19. Moldt B., Saye-Francisco K., Schultz N., Burton D.R., Hessell A.J. Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography. Methods 2014, 65:127.
20. Mouquet H. Antibody B cell responses in HIV-1 infection. Trends Immunol. 2014, 35:549.
21. Mouquet H., Scharf L., Euler Z., Liu Y., Eden C., Scheid J.F., Halper-Stromberg A., Gnanapragasam P.N., Spencer D.I., Seaman M.S., Schuitemaker H., Feizi T., Nussenzweig M.C., Bjorkman P.J. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3268.
22. Muellenbeck M.F., Ueberheide B., Amulic B., Epp A., Fenyo D., Busse C.E., Esen M., Theisen M., Mordmuller B., Wardemann H. Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies. J. Exp. Med. 2013, 210:389.
23. Ng Y.S., Wardemann H., Chelnis J., Cunningham-Rundles C., Meffre E. Bruton's tyrosine kinase is essential for human B cell tolerance. J. Exp. Med. 2004, 200:927.
24. Reinhart D., Weik R., Kunert R. Recombinant IgA production: single step affinity purification using camelid ligands and product characterization. J. Immunol. Methods 2012, 378:95.
25. Samuels J., Ng Y.S., Coupillaud C., Paget D., Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 2005, 201:1659.
26. Sandin C., Linse S., Areschoug T., Woof J.M., Reinholdt J., Lindahl G. Isolation and detection of human IgA using a streptococcal IgA-binding peptide. J. Immunol. 2002, 169:1357.
27. Scheid J.F., Mouquet H., Feldhahn N., Seaman M.S., Velinzon K., Pietzsch J., Ott R.G., Anthony R.M., Zebroski H., Hurley A., Phogat A., Chakrabarti B., Li Y., Connors M., Pereyra F., Walker B.D., Wardemann H., Ho D., Wyatt R.T., Mascola J.R., Ravetch J.V., Nussenzweig M.C. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458:636.
28. Scheid J.F., Mouquet H., Kofer J., Yurasov S., Nussenzweig M.C., Wardemann H. Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18044-18048.
29. Sullivan M., Kaur K., Pauli N., Wilson P.C. Harnessing the immune system's arsenal: producing human monoclonal antibodies for therapeutics and investigating immune responses. F1000 biology reports 2011, 3:17.
30. Thomas M., Klibanov A.M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 2003, 62:27.
31. Tiller T. Single B cell antibody technologies. N. Biotechnol. 2011, 28:453.
32. Tiller T., Tsuiji M., Yurasov S., Velinzon K., Nussenzweig M.C., Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity 2007, 26:205.
33. Tiller T., Meffre E., Yurasov S., Tsuiji M., Nussenzweig M.C., Wardemann H. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 2008, 329:112.
34. Tiller T., Busse C.E., Wardemann H. Cloning and expression of murine Ig genes from single B cells. J. Immunol. Methods 2009, 350:183.
35. Tsuiji M., Yurasov S., Velinzon K., Thomas S., Nussenzweig M.C., Wardemann H. A checkpoint for autoreactivity in human IgM+ memory B cell development. J. Exp. Med. 2006, 203:393.
36. Wardemann H., Nussenzweig M.C. B-cell self-tolerance in humans. Adv. Immunol. 2007, 95:83.
37. Wardemann H., Yurasov S., Schaefer A., Young J.W., Meffre E., Nussenzweig M.C. Predominant autoantibody production by early human B cell precursors. Science (New York, N.Y.) 2003, 301:1374.
38. Wilson P.C., Andrews S.F. Tools to therapeutically harness the human antibody response. Nat. Rev. Immunol. 2012, 12:709.
39. Wrammert J., Smith K., Miller J., Langley W.A., Kokko K., Larsen C., Zheng N.Y., Mays I., Garman L., Helms C., James J., Air G.M., Capra J.D., Ahmed R., Wilson P.C. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008, 453:667.
40. Yang X., Farzan M., Wyatt R., Sodroski J. Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins. J. Virol. 2000, 74:5716.
41. Yurasov S., Wardemann H., Hammersen J., Tsuiji M., Meffre E., Pascual V., Nussenzweig M.C. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 2005, 201:703.